CLOs on the Move

RI International

www.riinternational.com

 
With more than 51 programs across the U.S. and abroad, RI specializes in Crisis, Health, Recovery and Consulting Services. RI Crisis is rapidly expanding while enhancing technologies and service lines within our existing array of RRC`s(Crisis Stabilization Programs), E&Ts (Involuntary & Court-ordered Treatment), and Crisis Respites.
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Stilla Technologies

Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.

Virginia Mason Franciscan Health

Virginia Mason Franciscan Health is a health care provider that offers compassionate, quality health care throughout the Pacific Northwest and Puget Sound Area.

Hometrak

Hometrak is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

HealthSource Global

HealthSource Global is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ElectroCore

electroCore is, a US based electroceutical healthcare company, which is developing a range of non-invasive Vagus Nerve Stimulation (nVNS) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. Initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electroCore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the US (head office), Germany (German and European head office), UK, Italy, Australia, and Canada.